approval
saveOMLYCLO (OMALIZUMAB-IGEC) — FDA approval
community read0 votes
Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 1
same company · ±60 days · 6
- approvalSTEQEYMA: STEQEYMA (USTEKINUMAB-STBA) — FDA approvalDec 12, 2025
- approvalOSENVELT: OSENVELT (DENOSUMAB-BMWO) — FDA approvalOct 29, 2025
- approvalAVTOZMA: AVTOZMA (TOCILIZUMAB-ANOH) — FDA approvalJan 14, 2026
- approvalYUFLYMA: YUFLYMA (ADALIMUMAB-AATY) — FDA approvalOct 16, 2025
- approvalAVTOZMA: AVTOZMA (TOCILIZUMAB-ANOH) — FDA approvalJan 21, 2026
- approvalEYDENZELT: EYDENZELT (AFLIBERCEPT-BOAV) — FDA approvalOct 2, 2025
comments(0)
5-min edit window · permanent after that